JP2015049050A5 - - Google Patents

Download PDF

Info

Publication number: JP2015049050A5
Authority: JP; Japan
Prior art keywords: amount; test substance; urine; compounds represented; dysuria
Prior art date: 2013-08-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

JP2013178620A

Other languages

English (en)

Japanese (ja)

Other versions

JP2015049050A (ja

JP6222629B2 (ja

Filing date

2013-08-29

Publication date

2016-07-28

2013-08-29 Application filed filed Critical

2013-08-29 Priority to JP2013178620A priority Critical patent/JP6222629B2/ja

2013-08-29 Priority claimed from JP2013178620A external-priority patent/JP6222629B2/ja

2015-03-16 Publication of JP2015049050A publication Critical patent/JP2015049050A/ja

2016-07-28 Publication of JP2015049050A5 publication Critical patent/JP2015049050A5/ja

2017-11-01 Application granted granted Critical

2017-11-01 Publication of JP6222629B2 publication Critical patent/JP6222629B2/ja

Status Active legal-status Critical Current

2033-08-29 Anticipated expiration legal-status Critical

Links

150000001875 compounds Chemical class 0.000 claims 18
210000002700 Urine Anatomy 0.000 claims 7
239000000126 substance Substances 0.000 claims 7
206010013990 Dysuria Diseases 0.000 claims 6
208000009382 Urination Disorders Diseases 0.000 claims 4
239000003795 chemical substances by application Substances 0.000 claims 4
206010020853 Hypertonic bladder Diseases 0.000 claims 3
208000009722 Overactive Urinary Bladder Diseases 0.000 claims 3
230000027939 micturition Effects 0.000 claims 3
230000002730 additional Effects 0.000 claims 2
239000000090 biomarker Substances 0.000 claims 2
238000007689 inspection Methods 0.000 claims 2
238000005259 measurement Methods 0.000 claims 2
230000003449 preventive Effects 0.000 claims 2
230000003247 decreasing Effects 0.000 claims 1
238000010998 test method Methods 0.000 claims 1

JP2013178620A 2013-08-29 2013-08-29 排尿障害のバイオマーカー Active JP6222629B2 (ja)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
JP2013178620A JP6222629B2 (ja)	2013-08-29	2013-08-29	排尿障害のバイオマーカー

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2013178620A JP6222629B2 (ja)	2013-08-29	2013-08-29	排尿障害のバイオマーカー

Publications (3)

Publication Number	Publication Date
JP2015049050A JP2015049050A (ja)	2015-03-16
JP2015049050A5 true JP2015049050A5 (ru)	2016-07-28
JP6222629B2 JP6222629B2 (ja)	2017-11-01

Family

ID=52699210

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2013178620A Active JP6222629B2 (ja)	2013-08-29	2013-08-29	排尿障害のバイオマーカー

Country Status (1)

Country	Link
JP (1)	JP6222629B2 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP7294709B2 (ja) *	2017-09-29	2023-06-20	国立大学法人山梨大学	難治性夜間頻尿・夜間多尿症バイオマーカーの測定方法及び難治性夜間頻尿・夜間多尿症の予防剤又は改善剤のスクリーニング方法
JP7031104B2 (ja) *	2017-09-29	2022-03-08	国立大学法人山梨大学	難治性夜間頻尿・夜間多尿症バイオマーカー、これを用いた検査方法及び難治性夜間頻尿・夜間多尿症の予防剤又は改善剤のスクリーニング方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS59162899A (ja) *	1983-03-08	1984-09-13	Kyoto Daiichi Kagaku:Kk	β‐ヒドロキシ酪酸の定量用組成物
US7700792B2 (en) *	2003-12-26	2010-04-20	Ono Pharmaceutical Co., Ltd.	Highly active lysophosphatidic acid and method of screening therewith
EP2597464B1 (en) *	2007-08-16	2015-02-25	The Regents of the University of Michigan	Metabolomic profiling of prostate cancer
CN102483416A (zh) *	2009-06-04	2012-05-30	梅坦诺米克斯保健有限公司	诊断***癌的工具和方法
EP2517022A4 (en) *	2009-12-22	2013-07-10	Univ Michigan	METABOLOMIC PROFILING OF PROSTATE CANCER
EP2776832A4 (en) *	2011-11-11	2015-06-03	Metabolon Inc	BIOMARKER FOR BUBBLE CANCER AND METHOD FOR ITS USE

2013
- 2013-08-29 JP JP2013178620A patent/JP6222629B2/ja active Active

Similar Documents

Publication	Publication Date	Title
MX367046B (es)	2019-08-02	Marcadores especificos de via para diagnosticar sindrome del intestino irritable.
CA2863393A1 (en)	2013-08-15	A multi-biomarker-based outcome risk stratification model for pediatric septic shock
JP2016500110A5 (ru)	2017-01-05
EP3751283A3 (en)	2021-03-24	Blood-based screen for detecting neurological diseases in primary care settings
JP2018509934A5 (ru)	2019-03-14
EP2759259A3 (en)	2015-12-16	Apparatus and method for measuring stress based on a behavior of a user
JP2014144959A5 (ru)	2015-01-29
WO2015094995A3 (en)	2015-11-12	Gene signature biomarkers of tumor response to pd-1 antagonists
WO2016044338A3 (en)	2016-05-12	Methods and systems for diagnosing sleep disorders
JP2016531903A5 (ru)	2019-01-17
EP2579043A4 (en)	2013-12-04	DETECTION METHOD
JP2016512201A5 (ru)	2017-04-13
MX2021012347A (es)	2021-10-22	Composiciones, metodos y kits para el diagnostico de una neoplasia neuroendocrina gastroenteropancreatica.
JP2015520383A5 (ru)	2016-07-28
JP2017505897A5 (ru)	2017-12-14
EA201290793A1 (ru)	2013-04-30	Зонд для определения границ между веществами
JP2013527437A5 (ru)	2014-08-28
JP2013504766A5 (ru)	2013-10-31
JP2015049050A5 (ru)	2016-07-28
JP2010526995A5 (ru)	2011-02-17
WO2015006657A3 (en)	2015-02-19	Method for the diagnosis and prognosis of cancer
BR112012024175A2 (pt)	2016-07-05	hbf e a1m como marcadores de estágio precoce para preeclampsia
EP2385365A3 (en)	2012-07-18	Method for tumor detection using T1 measurements and a SQUID-based tabletop NMR system
JP2016080672A (ja)	2016-05-16	悪性リンパ腫の検出法
WO2016163727A3 (ko)	2017-03-23	황화수소 검출용 방사성 프로브